Update shared on 10 Dec 2025
Analysts have nudged their price target for Novanta slightly higher to align with its updated fair value of $154.00, reflecting modestly stronger confidence in the company’s steady growth and margin profile.
What's in the News
- Novanta completed a $550 million composite tangible equity units offering, issuing 11 million units priced at $50 each, with a $1.375 discount per unit (Key Developments).
- The company expects approximately $533 million in net proceeds from the tangible equity units offering, potentially rising to about $613 million if underwriters exercise their over allotment option (Key Developments).
- Novanta plans to use a portion of the proceeds to repay roughly $317 million outstanding on its revolving credit facility, while reserving remaining funds for acquisitions, investments, capital expenditures, share repurchases, and general corporate purposes (Key Developments).
- Management issued guidance calling for fourth quarter 2025 GAAP revenue of $253 million to $257 million and full year 2025 GAAP revenue of $975 million to $979 million, with mid single digit organic revenue growth targeted for full year 2026 (Key Developments).
- Under its ongoing buyback programs, Novanta has repurchased 182,964 shares for $21.61 million under a 2020 authorization, and separately authorized up to $200 million of additional share repurchases with no expiration date (Key Developments).
Valuation Changes
- Fair Value: unchanged at $154.00 per share, reflecting a stable central valuation estimate.
- Discount Rate: risen slightly from 8.74 percent to about 8.75 percent, signaling a marginally higher implied risk or return requirement.
- Revenue Growth: effectively unchanged at roughly 7.03 percent, indicating no meaningful revision to long term top line assumptions.
- Net Profit Margin: effectively unchanged at about 15.08 percent, maintaining prior expectations for profitability.
- Future P/E: risen slightly from about 39.04x to 39.05x, suggesting a modestly higher valuation multiple on forward earnings.
Have other thoughts on Novanta?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
